PAVmed Statistics
Total Valuation
PAVmed has a market cap or net worth of $12.59 million. The enterprise value is $42.92 million.
Important Dates
The last earnings date was Tuesday, March 25, 2025, before market open.
Earnings Date | Mar 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PAVmed has 16.79 million shares outstanding. The number of shares has increased by 802.87% in one year.
Current Share Class | 16.79M |
Shares Outstanding | 16.79M |
Shares Change (YoY) | +802.87% |
Shares Change (QoQ) | +196.70% |
Owned by Insiders (%) | 8.75% |
Owned by Institutions (%) | 6.37% |
Float | 12.74M |
Valuation Ratios
The trailing PE ratio is 1.51.
PE Ratio | 1.51 |
Forward PE | n/a |
PS Ratio | 2.42 |
Forward PS | 37.18 |
PB Ratio | -1.79 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 1.34 |
EV / Sales | 14.33 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
Current Ratio | 0.06 |
Quick Ratio | 0.04 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -988.60 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -87.19% |
Return on Invested Capital (ROIC) | -112.26% |
Return on Capital Employed (ROCE) | 929.52% |
Revenue Per Employee | $27,991 |
Profits Per Employee | $298,748 |
Employee Count | 107 |
Asset Turnover | 0.09 |
Inventory Turnover | 12.02 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.53% in the last 52 weeks. The beta is 1.19, so PAVmed's price volatility has been higher than the market average.
Beta (5Y) | 1.19 |
52-Week Price Change | -72.53% |
50-Day Moving Average | 0.70 |
200-Day Moving Average | 0.91 |
Relative Strength Index (RSI) | 52.14 |
Average Volume (20 Days) | 136,093 |
Short Selling Information
The latest short interest is 271,999, so 1.62% of the outstanding shares have been sold short.
Short Interest | 271,999 |
Short Previous Month | 318,656 |
Short % of Shares Out | 1.62% |
Short % of Float | 2.13% |
Short Ratio (days to cover) | 1.42 |
Income Statement
In the last 12 months, PAVmed had revenue of $3.00 million and earned $31.97 million in profits. Earnings per share was $0.50.
Revenue | 3.00M |
Gross Profit | -1.85M |
Operating Income | -44.49M |
Pretax Income | -61.46M |
Net Income | 31.97M |
EBITDA | -43.29M |
EBIT | -44.49M |
Earnings Per Share (EPS) | $0.50 |
Full Income Statement Balance Sheet
The company has $1.53 million in cash and $31.86 million in debt, giving a net cash position of -$30.33 million or -$1.81 per share.
Cash & Cash Equivalents | 1.53M |
Total Debt | 31.86M |
Net Cash | -30.33M |
Net Cash Per Share | -$1.81 |
Equity (Book Value) | -7.03M |
Book Value Per Share | -0.52 |
Working Capital | -33.28M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$33.55 million and capital expenditures -$55,000, giving a free cash flow of -$33.61 million.
Operating Cash Flow | -33.55M |
Capital Expenditures | -55,000 |
Free Cash Flow | -33.61M |
FCF Per Share | -$2.00 |
Full Cash Flow Statement Margins
Gross margin is -61.60%, with operating and profit margins of -1,485.38% and 1,328.58%.
Gross Margin | -61.60% |
Operating Margin | -1,485.38% |
Pretax Margin | 949.15% |
Profit Margin | 1,328.58% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PAVmed does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -802.87% |
Shareholder Yield | n/a |
Earnings Yield | 253.89% |
FCF Yield | -266.94% |
Dividend Details Analyst Forecast
The average price target for PAVmed is $19.00, which is 2,433.33% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $19.00 |
Price Target Difference | 2,433.33% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 153.17% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 7, 2023. It was a reverse split with a ratio of 0.0666667:1.
Last Split Date | Dec 7, 2023 |
Split Type | Reverse |
Split Ratio | 0.0666667:1 |
Scores
PAVmed has an Altman Z-Score of -17.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -17.41 |
Piotroski F-Score | 3 |